Duke receives $62 million grant to lead network for clinical research on antibacterial resistance
Note: There is multimedia content on this page which requires the Flash viewer.
To see it, download and install the Flash plugin here: Macromedia Flash Player
Investigators at Duke Medicine and the University of California San Francisco have been selected to oversee a nationwide research program on antibacterial resistance, directing the allocation of a $62 million federal grant from the National Institute of Allergy and Infectious Diseases. Vance Fowler, Jr., M.D., MHS, professor of medicine at Duke is co-principal investigator of the network.